Skip to main content

Animations

MJFF Publications

6791 - 6800 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2021
  • 2021
  • 2012
  • 2017
  • 2020
  • 2015
  • 2024
  • 2020
  • 2023
  • Summary Details
    OPEN
    Title: Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000010863
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Novel Associations of BST1 and LAMP3 With REM Sleep Behavior Disorder
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000011464
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012342
    Citation Count: 30
  • Summary Details
    OPEN
    Title: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9a
    Citation Count: 151
  • Summary Details
    OPEN
    Title: Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-017-0276-4
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?
    Journal Name: Neurological Research and Practice
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s42466-020-00076-y
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Large-scale assessment of polyglutamine repeat expansions in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000002016
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Parkinson’s disease psychosis associated with accelerated multidomain cognitive decline
    Journal Name: BMJ Mental Health
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/bmjment-2024-301062
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Striatal dopaminergic denervation and hypomimia in Parkinson's disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ene.14483
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Unconventional initiation of PINK1/Parkin mitophagy by Optineurin
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2023.04.021
    Citation Count: 79
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.